ArticleThe Lancet regional health. Southeast Asia2026
Burden of diarrhoeal diseases among hospitalised patients in Thailand: a retrospective national database analysis (2014-2022).
Article in The Lancet regional health. Southeast Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute diarrhoea remains one of the leading causes of morbidity and mortality worldwide. Most existing research has focused on children younger than 5 years of age, while data from Thailand are limited. In this study we characterised trend of diarrhoeal admissions, associated Disability-adjusted life years (DALYs) and determined predictors of mortality and high-cost admissions in Thailand. Methods: We analysed Thailand's National Health Security Office inpatient claims database for 2014-2022. We estimated admission rates (ASRs), costs of admission ($PPP), and DALYs for pre-pandemic (2014-2019) and pandemic (2020-2022) periods. Predictors of mortality and high-cost admission were assessed using logistic regression. Rotavirus vaccine impact was evaluated among children younger than 5 years of age. Findings: Among 3,041,699 total admissions, 54·3% were female, median age was 22 years (IQR 3-61). ASR fell from 686·5/100,000 pre-pandemic to 474·5/100,000 pandemic, while mean cost rose from $PPP 372 to 539. The case fatality ratio was 0·6 (18,782 deaths). Total burden was 1,124,618 DALYs; mean annual DALYs fell from 132,366 to 110,140. Children younger than 5 years of age accounted for 31·4% of admissions, whereas adults older than or equal to 60 years of age accounted for 25·7% of admissions and 64·6% of total deaths. Older age, male sex, referral hospitals, central region, stroke, sepsis, respiratory failure, and Interpretation: Thailand's diarrhoeal admissions were concentrated among young children and older adults, with mortality and high-cost admissions driven by Funding: This research was funded by Wellcome (grant number 315982/Z/24/1). For the purposes of open access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.